- Home
- DFP vs CLPT Comparison
DFP vs CLPT Comparison
Compare DFP & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DFP | CLPT |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.5M | 467.9M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | DFP | CLPT |
|---|---|---|
| Price | $20.20 | $14.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 43.7K | ★ 500.5K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 6.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $19.56 | $8.27 |
| 52 Week High | $22.11 | $30.10 |
Technical Indicators
Market Signals| Indicator | DFP | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 41.94 |
| Support Level | $20.14 | $12.47 |
| Resistance Level | $21.05 | $15.18 |
| Average True Range (ATR) | 0.13 | 0.88 |
| MACD | -0.05 | -0.14 |
| Stochastic Oscillator | 3.18 | 10.43 |
Price Performance
Historical ComparisonAbout DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.